Sussan, Thomas

Public Health - Environmental Health Science

The airway microbiome in COPD exacerbations of smokers and never-smokers in India

Chronic Obstructive Pulmonary Disease (COPD) is the third-leading cause of death globally. In the developed world, the primary risk factor for COPD is cigarette smoking, while in the developing world (including India), 30-50% of COPD patients are never-smokers. Major risk factors for non-smoking COPD are exposure to high levels of household air pollution and/or ambient air pollution. COPD exacerbations, defined as acute worsening of respiratory symptoms, are the major cause for morbidity and mortality. Due to poor immune defenses, bacterial infections are the predominant cause of exacerbations and prevention and management of exacerbations have been major public health challenges. Current knowledge of the airway microbiome (pathogenic bacteria) associated with exacerbations and treatment regimens to combat these are from smoking COPD patients of developed countries. However, little is known about the airway microbiome that causes exacerbations in the developing world, and more importantly, it is also unclear whether the airway microbiome of non-smoking COPD differs from smoking COPD. The aim of this pilot study is to identify the airway microbiome of Indian smoking COPD and non-smoking COPD during exacerbations, in order to determine i) exacerbation-causing bacterial species amongst Indian COPD patients; ii) whether the causal microbiota in smoking COPD is different from non-smoking COPD; and iii) whether this warrants different preventive/treatment modalities to reduce the severity for smoking or non-smoking COPD subjects. JHSPH has recently partnered with JIPMER, a leading medical institute in India, and the PI’s team is uniquely positioned to conduct this pilot study and forge a relationship for future large studies. The findings of the study may assist physicians in making therapeutic decisions that are most effective and also aid in development of improved methods of diagnosis, prevention (e.g., vaccination) and treatment (e.g. antibiotics) of COPD exacerbations, which can save lives in India and other areas of the world.  

Daniel Peterson, JHSOM, Pathology; Alan Scott, JHSPH, Molecular Microbiology and Immunology; Shyam Biswal, JHSPH, Environmental Health Sciences

People

Stefan Baral, MD MPH,MBA,MSc

Director, Key Populations Program

Yukari C. Manabe, MD

Associate Director of Global Health Research and Innovation

Noreen Hynes, MD MPH

Director, Geographic Medicine Center of the Division of Infectious Diseases

Robert Bollinger Jr., MD MPH

Director, Johns Hopkins Center for Clinical Global Health Education (CCGHE); Associate Director, Johns Hopkins Center for Global...

Caitlin Kennedy, PhD MPH,BA

Co-Director, MPH concentration in Social and Behavioral Sciences in Public Health; Associate Director, Center for Qualitative...

Joanne Katz, ScD MS,BSc

Associate Chair, Director of Academic Programs
«

September 2018

»
S
M
T
W
T
F
S
·
·
·
·
·
·
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
·
·
·
·
·
·

Projects

Building an Enabling Environment for Vaccines in India...

This project, now in its second phase, aims to create an enabling environment for vaccines in India and contribute to...

Read More

Mpilonhle

Mpilonhle brings multi-dimensional services to adolescents in rural South Africa. Its objective is to reduce the very high...

Read More

Identification and Enumeration of Pathogens in Drinking...

CWH researchers are using polymerase chain reaction and mass spectrometry technologies to develop a microbial isolation and...

Read More

Nutrition Innovation Lab

"Poshan", which means good nutrition in Nepali is ongoing research that involves two interlinked large-scale research studies...

Read More